Outcome of the Board meeting along with the financial results for the year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
EP Biocomposites Ltd reported audited financial results for FY 2025-26. Revenue from operations grew to Rs 1,363.98 lakhs from Rs 1,200.62 lakhs in the previous year, representing approximately 13.6% growth. Profit after tax increased significantly to Rs 145.83 lakhs from Rs 103.08 lakhs, marking a 41.5% increase. Basic and diluted EPS improved to Rs 8.67 per share from Rs 6.13. The company completed an IPO of 5.04 lakh equity shares at Rs 126 per share, raising Rs 580.04 lakhs (net of expenses). Operating cash flow turned positive at Rs 198.94 lakhs compared to a negative Rs 48.98 lakhs in the prior year. Long-term borrowings decreased from Rs 245.15 lakhs to Rs 186.96 lakhs.
Strong financial performance with double-digit revenue growth and robust PAT growth. Improved cash generation and reduced debt are positive indicators for shareholders. The company appears to be managing its IPO proceeds effectively with funds deployed for working capital, lease deposits, and loan repayment as planned.